In one small-scale in vitro screen, 21 clinically relevant cancer drugs were tested alone or in combination with MEK or PI3K inhibitors in both 2D and 3D cultures of NF1-deficient HGG cells [140]. The gene discussed is NF1; the disease is cancer.